When GLP‑1 Weight Loss Jabs Don’t Work: What Next?
This is our third article on GLP-1 drugs, a hot topic in all media. With a growing number of people presenting with concerning symptoms in the clinic, there is increasing awareness in the field of holistic health, with many prominent experts sharing their clinical experience and ways to support our clients and patients.
As naturopaths, our mission is always to work with the body, not against it, and provide a fully individualised approach. And, when patients or clients are on certain medications, we also need to work around them to prevent complications from side effects or interactions with supplements or specific foods. Our work is, therefore, never easy nor straightforward. This is why we spend so much time with our clients/patients. We need to know their complete medical history, antecedents, and any potential causes of symptoms or conditions. On the other hand, over-stretched doctors will prescribe a drug within minutes according to your presenting symptoms and not much else, as they are probably already running half an hour late by 9:30 in the morning.
Today, the mission remains the same: I am here to empower you with knowledge and let you decide what is best for you.
First, it is essential to reiterate that weight loss jabs were initially created to support weight loss in overweight or obese people, who would otherwise have an increased risk of comorbidities and poorer quality of life. Nowadays, a trend ignited by Hollywood stars has led otherwise “healthy” people to use drugs to shed extra weight to become skinnier, at the expense of balanced nutrition and minimum energy requirements. Very often, these individuals present with serious side effects, some that health practitioners wouldn’t expect, like severe nutrient deficiencies leading to conditions like sarcopenia, osteopenia, but also scurvy, brain fog, and poor emotional regulation. Some also experience hormonal dysregulation. The effects may be so severe that they must discontinue the drugs.
For people with a lot of extra weight, the drugs are presented as the best solution for a healthier outcome. However, the drugs may not work, and they are faced with many questions, feeling defeated and potentially depressed.
Indeed, GLP‑1 weight loss injections such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are often presented as near‑guaranteed solutions for people living with obesity. In clinical trials, a large majority of participants do achieve clinically meaningful weight loss, usually defined as at least 5–10% of starting body weight (over a year). But that is not the whole story. Around 10–15% of people in semaglutide trials did not reach “clinically significant” weight loss, even when the drug was taken as prescribed and combined with lifestyle advice. Being a “non‑responder” can be confusing and demoralising, especially when social media is flooded with dramatic before‑and‑after photos.
This article explores why GLP‑1 weight loss medications may not work as expected, what “non‑response” really means, and what practical, evidence‑informed steps you can take if you are not seeing the results you hoped for.
What Does “Non‑Response” to GLP‑1 Actually Mean?
In obesity medicine and clinical trials, response to a GLP‑1 medication is usually defined by percentage weight loss over a given time. For example, one trial using 2.4 mg weekly semaglutide found that about 86% of participants lost at least 5% of their body weight over 68 weeks, while roughly 14% did not reach that threshold. Some obesity specialists aim for 10–15% weight loss, because that level is often associated with more meaningful improvements in metabolic markers such as blood pressure, blood glucose, and lipids.
Non‑response does not necessarily mean “no effect at all.” Some people may experience reduced appetite, improved blood sugar control, or small weight changes that fall below the research cut-off. Others may lose weight initially and then plateau earlier than expected. A smaller group will not lose significant weight despite appropriate dosing. Understanding why that happens requires looking beyond the medication alone.
Lifestyle Still Matters, Even on GLP‑1
One of the most important messages, often lost in media coverage, is that GLP‑1 drugs in trials were never used in isolation. Participants typically received structured lifestyle support, including nutrition guidance, physical activity recommendations, and behavioural counselling, regardless of group assignment. When these foundations are missing in real life, the effectiveness of the medication can be blunted.
Clinicians emphasise that the classic pillars of lifestyle medicine: diet quality, regular movement, sleep, stress management, avoidance of harmful substances, and social connection, remain essential, even when someone is on a potent anti‑obesity drug. GLP‑1 receptor agonists may help reduce appetite and make it easier to eat less, but they do not automatically change what someone eats, how they sleep, how they cope with stress, or how active they are. If ultra‑processed, high‑calorie foods still dominate, emotional eating remains unaddressed, or sleep and stress are severely disrupted, weight loss may stall despite the injection.
Exercise is particularly important. Weight loss of any kind tends to reduce both fat mass and lean mass, and GLP‑1‑induced weight loss is no exception. Resistance and aerobic exercise can help preserve muscle, support bone health, improve insulin sensitivity, and enhance overall energy expenditure, all of which influence long‑term outcomes.
“GLP‑1 drugs in trials were never used in isolation. Participants typically received structured lifestyle support, including nutrition guidance, physical activity recommendations, and behavioural counselling, regardless of group assignment. When these foundations are missing in real life, the effectiveness of the medication can be blunted.”
Medication Adherence, Dosing, and Duration
Another common reason for limited weight loss is how the drug is taken in real life. In clinical trials, adherence is closely monitored, and participants are typically followed for around 68 weeks or longer. Outside of trials, a substantial proportion of people discontinue GLP‑1 medications within a year due to cost, supply issues, side effects, or simple difficulty maintaining the routine. Pharmacy benefit manager data cited by Healthline suggested that only about one‑third of people were still using Ozempic or Wegovy after one year in one analysis.
GLP‑1 agonists usually require a stepwise dose escalation and consistent weekly or daily dosing to achieve optimal appetite suppression and metabolic benefits. Missing doses, stopping too early, not reaching the therapeutic dose, or frequent on-and-off switching can all reduce effectiveness. Trials also show that when semaglutide is stopped after significant weight loss, much of the lost weight tends to return within a year, underscoring the need for ongoing treatment or carefully managed maintenance strategies.
Underlying Medical Conditions and Co‑Medications
Weight regulation is influenced by multiple biological systems, including thyroid function, sleep quality, sex hormones, gut hormones, and the brain’s regulation of appetite and reward. Many clinicians highlight conditions such as untreated hypothyroidism, sleep apnoea, chronic insomnia, and binge eating disorder as potential reasons why GLP‑1 drugs might underperform unless those conditions are identified and treated. If sleep is chronically poor, for example, hormonal changes in leptin and ghrelin may increase hunger and reduce energy, undermining weight‑loss efforts regardless of medication.
Co‑medications also matter. Some commonly used drugs, including certain antidepressants, antipsychotics, beta‑blockers and others, are known to promote weight gain or interfere with weight loss. If someone is taking a GLP‑1 agonist alongside a strongly weight‑promoting medication, the net effect on body weight can be modest or even neutral. This does not mean GLP‑1 drugs “don’t work” in a mechanistic sense; it means their effects are offset by other biological pressures. In such situations, reviewing the overall medication regimen with a knowledgeable prescriber should be the first step.
Insulin Resistance, Type 2 Diabetes, and Expectations
GLP‑1 receptor agonists were initially developed for type 2 diabetes, and they remain key tools in diabetes management. However, some data suggest that people with long‑standing metabolic disease or severe insulin resistance may lose less weight on GLP‑1 medications than people without diabetes, all else being equal. Chronic hyperinsulinaemia, beta‑cell dysfunction, and long‑term metabolic adaptation can make weight loss more challenging, so even when appetite is reduced, the weight response may be slower or less dramatic.
In those cases, GLP‑1 therapy can still be beneficial, improving glycaemic control and cardiovascular risk, even if headline weight‑loss percentages are lower. For these patients, success may need to be defined more broadly: better blood sugar control, reduced medication burden, improved energy, and risk reduction, rather than a specific number on the scale.
Psychological and Behavioural Factors
GLP‑1 receptor agonists can sometimes help reduce binge episodes or constant food preoccupation, but they are not stand‑alone treatments for eating disorders or deep‑seated emotional relationships with food. If someone uses food primarily for comfort, reward, or emotional regulation, the medication may blunt hunger but not address the underlying drivers. In some cases, people may “eat around” the drug by choosing more energy‑dense foods or continuing to graze despite reduced appetite signals.
Stress, trauma, and mental health conditions such as depression and anxiety also influence behaviour, motivation, and self‑care. Studies on weight loss consistently show that adding psychological support, through counselling, cognitive‑behavioural therapy, or group programmes, improves outcomes compared to pharmacology alone. When this piece is missing, it is more likely that old patterns will re‑emerge under pressure, regardless of the medication.
What To Do If You Aren’t Losing Weight on GLP‑1
If you are several months into a GLP‑1 medication and not experiencing the weight loss you or your clinician expected, there are several evidence‑aligned steps to consider.
First, give the process a reasonable trial under supervision. Experts quoted by Healthline generally recommend at least 12 weeks at a therapeutic dose before deciding that a regimen is ineffective. Early data suggest that people who show some degree of response by around 20 weeks are more likely to achieve larger weight losses by 68 weeks, but not everyone follows the same trajectory. Also, remember that the clinical studies provide a weight loss of 5-10% after 12 months.
Second, have an honest, detailed review with your prescriber. This conversation should cover dosing, adherence (missed doses, timing issues), side effects, co‑medications, and any underlying conditions that might be interfering, such as thyroid disease, sleep disorders, or suspected eating disorders. Adjustments might include dose titration, management of side effects to help you stay on the medication consistently, or investigation of other health issues.
Third, take a close look at your lifestyle foundation, not in a blaming way but as data collection. Are you stopping when you are comfortably full, or still eating until stuffed out of habit? How much of your intake is coming from whole or minimally processed foods versus ultra‑processed products? Are you moving your body regularly in ways that are realistic for your health status? How are you sleeping? Where is stress sitting in your life?
Small, sustainable changes here can potentiate the drug’s effect without demanding perfection.
Fourth, consider psychological support. If emotional eating, body image distress, or long‑standing trauma around food and weight are part of your story, a GLP‑1 agonist will not solve those issues on its own. Working with a therapist, counsellor, or support group experienced in eating behaviour and chronic illness can help you build more supportive patterns that complement the medication.
Finally, discuss alternatives. Not everyone responds to a particular GLP‑1 drug, and some people tolerate one compound or combination better than another. For example, new dual GIP/GLP‑1 agonist drugs have, on average, shown greater weight loss than GLP‑1 agonists alone in some trials, although individual responses vary. Other classes of anti‑obesity medications, or non‑pharmacological options such as bariatric surgery, may be appropriate in specific cases. The key is to tailor the approach to the person rather than forcing everyone to respond the same way to a single drug.
Finally, many natural supplements can provide similar results to the jabs without the side effects, and this is where naturopathy comes in, as it places you at the centre of your care, responsibilising you to take ownership of your health and empower you with the knowledge to take decisive action to improve your health with a targeted approach that is based on your current situation, including environment (relationships and support, economic status, sleep, diet, lifestyle, etc.).
Reframing Success Beyond the Scale
It is understandable to feel disappointed or frustrated if a much‑hyped weight loss injection does not produce the transformation you were led to expect. However, there is value in stepping back and broadening the definition of success. For some, GLP‑1 treatment might primarily improve blood sugars, reduce cravings, or stabilise eating patterns, even if weight changes are modest. For others, the main benefit could be reduced risk of cardiovascular events or the ability to reduce other medications. This, on its own, is a massive achievement, providing improved health outcomes and better quality of life.
The most important question is not “Did I get the same result as an influencer?” It is “Is this treatment, in the context of my life and health, moving me towards better overall wellbeing, or not?” If the answer is no, that is not a personal failure; it is information that can guide the next step in your care.
Weight science is complex, and human lives are even more so. GLP‑1 receptor agonists are powerful tools, but they are not universal solutions. A thoughtful, individualised, and compassionate approach, combining medical oversight, nutritional and psychological support, and realistic expectations, offers the best chance of harnessing benefits while reducing harm.
If you are not seeing the results you hoped for on a GLP‑1 medication, the most constructive move is not to blame yourself or to give up entirely. It is to ask better questions, gather more data, and work with a team willing to look beyond the injection and treat you as a whole person.
Key Takeaways
GLP‑1 drugs can be hugely helpful for some people, but are not guaranteed weight‑loss solutions for everyone.
Non‑response often reflects a mix of biology, co‑medications, lifestyle factors, and how the drug is used—not personal failure.
Medical oversight, nutrition support, resistance exercise, and psychological care markedly improve safety and outcomes.
Success should be defined by broader health and quality‑of‑life gains, not just a number on the scale.
FAQs
Why Isn’t My Weight Loss Jab Working?
Q1. Is it my fault that I’m not losing weight on a GLP‑1 medication?
Absolutely not. People respond very differently to weight‑loss medications. Factors like genetics, hormones, other health conditions, current medications, sleep, stress, and what you’re able to eat and do day‑to‑day all play a role. Not seeing big changes on the scales does not mean you’ve failed or that your body is “broken.”
Q2. How long should I wait before worrying that it’s not working?
Most specialists suggest giving the medication at least 12 weeks at a therapeutic dose before deciding it isn’t helping enough. You may see small changes earlier, but it can take several months to understand your personal response. If you are worried at any point, it’s always reasonable to book a review rather than stopping on your own. Also, remember that studies are often based on a modest weight loss of 5-10% after 12 months.
Q3. Can lifestyle still make a difference if I’m already on a jab?
Yes, very much so. These medications can help you feel fuller and reduce appetite, but they can’t choose foods, cook meals, improve sleep, or manage stress for you. Gentle tweaks, like eating more protein and fibre, moving your body in ways you can manage, and working on sleep, often make the medication work better. Small, sustainable changes are far more important than perfection.
Q4. What if I’m eating very little but still not losing much?
Sometimes appetite drops sharply, and portions shrink, yet weight loss remains slower than expected. This can happen if your body has adapted to years of dieting, if you have underlying conditions (such as thyroid problems or sleep apnoea), or if you’re on other medications that promote weight gain. It can also mean your body is prioritising safety over speed. This is a good time to ask your clinician to check for medical issues, review your other medications, and make sure you’re getting enough protein and key nutrients, not just fewer calories.
Q5. Why did I lose weight at first and then plateau?
Most people’s weight loss slows down or plateaus after the first few months; this is normal biology. Your body adjusts, energy needs change, and water shifts stabilise. A plateau doesn’t mean the medication has “stopped working”; it’s often a sign to reassess your dose, your routine, and your health more broadly. Sometimes maintaining a lower weight and focusing on strength, energy, and metabolic health is a bigger win than chasing an ever‑smaller number.
This is the same phenomenon that happens with any crash diet. The sudden reduction in food intake (and calories) forces the body into starvation mode, prompting the release of stress hormones to regulate metabolism. What is happening is that you may lose lean muscle mass while the body is conserving as much energy as possible as adipose tissue (fat). So you think you are losing weight because muscle is lighter than fat, all the while disturbing your metabolism and putting on fat. Once you reintroduce food, you put the weight back on and some. This is basic human biology, and it is not talked about enough.
Q6. Could other health problems or medicines be getting in the way?
Yes. Conditions such as untreated hypothyroidism, sleep apnoea, chronic insomnia, depression, or binge‑eating can all blunt weight‑loss responses. Some common medicines, including certain antidepressants, antipsychotics, steroids, and beta‑blockers, can also make weight loss harder (some often lead to water retention, making you feel that you are putting on weight). None of this means you’re doing something wrong; it just means your biology needs a more tailored plan. Your prescriber can help identify and, where appropriate, adjust these factors.
Q7. What should I talk to my doctor or nurse about?
Bring your questions and your data. Note your starting weight, current weight, dose changes, side effects, other medications, sleep, mood, and how you’re eating and moving. Ask:
Is my dose right for me yet?
Are there health conditions or medicines that might be slowing my progress?
What blood tests or checks would be useful now?
Are there nutrition or psychology referrals available to support me alongside the medication?
Q8. Are there other options if this jab really doesn’t suit me?
Yes. GLP‑1 injections are not the only tools available. Other weight‑management medications, different GLP‑1 or dual‑agonist drugs, structured lifestyle programmes, and, in some cases, bariatric surgery may all be considered, depending on your health and history. If one option isn’t giving you the benefits you’d hoped for, it’s reasonable to discuss alternatives rather than staying stuck and discouraged.
If you are looking for long-term wellness and sustained weight loss, considering a naturopathic approach is essential, especially if you want to work with natural aids rather than drugs.
Q9. How should I measure “success” if the scales aren’t moving much?
Weight is only one piece of your health picture. It’s also worth noticing changes in waist size, blood pressure, blood sugar, cholesterol, energy, sleep, mobility, and how you feel in daily life. For some people, better metabolic health, less breathlessness, or reduced cravings are meaningful wins, even if the number on the scale shifts more slowly than expected.
There are no shortcuts in life. Health requires effort, while being unhealthy and chronically sick comes so easily, and often just by doing nothing. I am not considering individuals with ongoing health issues that lead to weight gain; I am discussing people with unchecked insulin resistance and type 2 diabetes, which is typically a symptom of a sedentary lifestyle, overeating (or eating an ultra-processed diet, or grazing throughout the day), or extreme stress, etc.
Q10. What’s the most important thing for me to remember?
You deserve care, not blame. These medications are powerful, but they are not magic, and they are not the whole solution. If your weight loss jab isn’t working the way you hoped, it is a signal to pause, review, and adjust the plan, not a verdict on your willpower or worth. Reaching out for proper medical, nutritional, and emotional support is a strength, and there are always next steps to explore.
Comment via LinkedIn
Such an important perspective.
Across our networks of pharmacies and supplement buyers worldwide, we see many individuals quietly struggling with this exact issue — doing “everything right” on GLP-1 therapy yet losing far less weight than expected. Your point is essential: non-response isn’t failure, and it isn’t always within someone’s control. Sleep, stress, underlying metabolic conditions, concurrent medications, and even psychological burden can completely change the outcome. 💥
What your article does so well is bring context and compassion back into a conversation that has become dominated by dramatic success stories. People need to hear that metabolic health is multifactorial, and that a plateau is not a moral flaw — it’s a signal that deeper assessment is needed.
The reminder to have a constructive review with a clinician, instead of internalising shame, is one of the most valuable messages for this community. 💊
Vitauz Global